We are live on
!
Find out more
Russell Investments Group Portfolio holdings
AUM
$114B
1-Year Est. Return
41.71%
This Fund
S&P 500
This Quarter
Est. Return
-1.29%
1 Year Est. Return
+41.71%
3 Year Est. Return
+123.74%
5 Year Est. Return
+158.32%
10 Year Est. Return
–
AUM
$72.8B
AUM Growth
+$380M
(+0.52%)
Cap. Flow
+$6.81B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
21.9%
Holding
3,928
New
233
Increased
1,953
Reduced
1,289
Closed
138
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
|
+$4.09B |
| 2 |
Apple
AAPL
|
+$167M |
| 3 |
Amazon
AMZN
|
+$158M |
| 4 |
Broadcom
AVGO
|
+$137M |
| 5 |
KKR.PRD
KKR & Co 6.25% Series D Preferred Stock
KKR.PRD
|
+$118M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America Series L
BAC.PRL
|
+$246M |
| 2 |
Vistra
VST
|
+$94.2M |
| 3 |
Philip Morris
PM
|
+$70.3M |
| 4 |
Applovin
APP
|
+$61.7M |
| 5 |
Eli Lilly
LLY
|
+$57.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.46% |
| 2 | Financials | 14% |
| 3 | Healthcare | 10.99% |
| 4 | Consumer Discretionary | 10.5% |
| 5 | Communication Services | 8.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2751
4D Molecular Therapeutics
FDMT
$609M
| $63.1K | ﹤0.01% |
+19,532
| New | +$92K |
|
2752
Fate Therapeutics
FATE
$294M
| $62.7K | ﹤0.01% |
79,377
-10,446
| -12% | -$12.8K |
|
2753
WisdomTree
WT
$3.44B
| $62.3K | ﹤0.01% |
6,986
+6,172
| +758% | +$57.5K |
|
2754
The RMR Group
RMR
$346M
| $62.1K | ﹤0.01% |
3,728
-29,490
| -89% | -$542K |
|
2755
Puma Biotechnology
PBYI
$450M
| $61.8K | ﹤0.01% |
20,893
+20,873
| +104,365% | +$65.3K |
|
2756
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
$36.8B
| $61.7K | ﹤0.01% |
1,208
+998
| +475% | +$51.8K |
|
2757
Sweetgreen
SG
$721M
| $61.5K | ﹤0.01% |
2,457
-104,331
| -98% | -$2.88M |
|
2758
PC Connection
CNXN
$2.04B
| $61.2K | ﹤0.01% |
980
+966
| +6,900% | +$64.2K |
|
2759
ProShares S&P MidCap 400 Dividend Aristocrats ETF
REGL
$1.82B
| $61.1K | ﹤0.01% |
757
-34
| -4% | -$2.77K |
|
2760
Health Catalyst
HCAT
$132M
| $61K | ﹤0.01% |
13,455
-64,835
| -83% | -$343K |
|
2761
Global X US Infrastructure Development ETF
PAVE
$14.3B
| $60.7K | ﹤0.01% |
1,609
-509
| -24% | -$20.6K |
|
2762
Flywire
FLYW
$2.22B
| $60.7K | ﹤0.01% |
6,385
-23,479
| -79% | -$370K |
|
2763
Vanguard Total International Stock ETF
VXUS
$164B
| $60.1K | ﹤0.01% |
968
-81
| -8% | -$5K |
|
2764
iShares ESG Aware MSCI USA Small-Cap ETF
ESML
$2.96B
| $60.1K | ﹤0.01% |
1,564
-66
| -4% | -$2.74K |
|
2765
Leslie's
LESL
$7.21M
| $59.8K | ﹤0.01% |
4,063
+4,040
| +17,565% | +$124K |
|
2766
Amphastar Pharmaceuticals
AMPH
$858M
| $59.7K | ﹤0.01% |
2,058
+1,862
| +950% | +$59.5K |
|
2767
Privia Health
PRVA
$2.78B
| $59.6K | ﹤0.01% |
2,657
+2,567
| +2,852% | +$59.6K |
|
2768
Intellia Therapeutics
NTLA
$1.66B
| $59.4K | ﹤0.01% |
8,351
-109,064
| -93% | -$1.1M |
|
2769
Amplitude
AMPL
$1.66B
| $59.3K | ﹤0.01% |
5,818
+1,455
| +33% | +$17.2K |
|
2770
Kodiak Sciences
KOD
$2.5B
| $59K | ﹤0.01% |
21,039
+18,504
| +730% | +$101K |
|
2771
State Street SPDR Portfolio S&P 400 Mid Cap ETF
SPMD
$19.1B
| $58.9K | ﹤0.01% |
+1,151
| New | +$62.7K |
|
2772
GigaCloud Technology
GCT
$1.9B
| $58.9K | ﹤0.01% |
4,148
+3,645
| +725% | +$66.5K |
|
2773
iShares Core S&P Total US Stock Market ETF
ITOT
$98.5B
| $58.8K | ﹤0.01% |
482
-72
| -13% | -$9.28K |
|
2774
Nordic American Tanker
NAT
$1.4B
| $58.8K | ﹤0.01% |
23,886
+3,875
| +19% | +$10.2K |
|
|
UCTT
2775
Ultra Clean Holdings
UCTT
$4.21B
| $58.7K | ﹤0.01% |
2,744
+2,272
| +481% | +$72.6K |
|
Similar funds
Russell Investments Group's Q1 2025 Portfolio in Review
As of Q1 2025, Russell Investments Group held 3,928 positions worth $72.8B, up 0.52% from $72.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Russell Investments Group deployed $6.81B of net new capital in Q1 2025, opening 233 new positions and adding to 1,953 existing holdings. Its largest new stake was Wells Fargo 7.5% Non Cumv Perp Conv: 3,389,000 shares worth $4.07M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 27% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Bank of America Series L, an estimated $246M trimmed.
- Russell Investments Group's largest Q1 2025 buy was Wells Fargo 7.5% Non Cumv Perp Conv: 3,389,000 shares worth $4.07M.
- Russell Investments Group added most to Apple in Q1 2025, an estimated $167M increase.
- Russell Investments Group's biggest Q1 2025 reduction was Bank of America Series L, cutting an estimated $246M.
- Russell Investments Group fully exited Arcadium Lithium plc in Q1 2025, selling an estimated $9.31M.
- Russell Investments Group's ten largest holdings make up 22% of its $72.8B portfolio in Q1 2025.
- Russell Investments Group opened 233 new positions and closed 138 in Q1 2025.
- Russell Investments Group's portfolio value rose 0.52% quarter-over-quarter to $72.8B.
Based on Russell Investments Group's 13F filing for Q1 2025, filed 13 May 2025.